Diabetes Clinical Trials in Nashville

Showing 61-80 of 593 trials

Multicenter Assessment of the Pancreas in Type 1 Diabetes

NCT03585153

The overall goal of this research is to develop and validate standard operating procedures (SOP) to assess the human pancreas in individuals with type 1 diabetes (T1D) and other forms of diabetes using advanced, quantitative magnetic resonance imaging (MRI) approaches.

Diabetes Mellitus

Vanderbilt University Medical Center250 participantsStarted Feb 2014

Aurora, Colorado, United States • Chicago, Illinois, United States • Nashville, Tennessee, United States +2 more locations

Not Yet RecruitingPhase 2< 1 mile

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

NCT07142252

This Phase 2 study is a 2-arm, multi-center, double-masked, placebo-controlled, 2:1 randomized sequential trial design in new onset T1D participants (within 100 days of diagnosis). Participants will be administered rezpegaldesleukin/placebo once every 14 days over 26 weeks with an additional 6-month follow-up period.

Type 1 Diabetes Mellitus

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)66 participantsStarted Nov 2025

Nashville, Tennessee, United States

TERMINATEDPhase 2< 1 mile

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

NCT07030868

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.

ObesityOverweightType 2 Diabetes

Eli Lilly and Company1 participantsStarted Jun 2025

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Greenbrae, California, United States +39 more locations

Multicenter Assessment of the Pancreas in Type 1 Diabetes

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Diabetes Trials in Other Cities

OP5-005 Using Omnipod 5 in Adults With Type 2

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Omnipod 5 System Compared to Pump Therapy

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

HLA Demographics Study in Adults With Type 1 Diabetes

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Other Conditions in Nashville